Ikarian Capital, LLC Amicus Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $1.3 Million - $2.05 Million	-164,174 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $2.46 Million - $3.11 Million	-250,000 Reduced 60.36%	164,174 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $635,170 - $860,460	72,674 Added 21.28%	414,174 $3.95 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $3.14 Million - $8.15 Million	341,500 New	341,500 $3.37 Million

310

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.